(Q40596850)

English

A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Hönemann D

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kufer P

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rimpler MM

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Chatterjee M

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Friedl S

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Riecher F

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bommert K

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dörken B

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bargou RC

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

636-644

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

MHC restricted and non-restricted killer lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Clinical experience with CD3 x CD19 bispecific antibodies in patients with B cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

The use of hybrid hybridomas to target human cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Engineering high affinity humanized anti‐p185HER2/anti‐CD3 bispecific F(ab′)2 for efficient lysis of p185HER2 overexpressing tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

21 January 2018

Multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Wue-1, a novel monoclonal antibody that stimulates the growth of plasmacytoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Inter-active-site distance and solution dynamics of a bivalent-bispecific single-chain antibody molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (alpha CD3/alpha CD19)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403264

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403264

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40596850&oldid=2203816144"